A comparison of acepromazine-buprenorphine and medetomidine-buprenorphine for preanesthetic medication of dogs

Journal of the American Veterinary Medical Association

Volumn 237, Issue 12, 2010, Pages 1431-1437

  Grint, Nicola J ^a   Alderson, Briony ^b   Dugdale, Alexandra H A ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; BUPRENORPHINE; DOPAMINE RECEPTOR BLOCKING AGENT; HYPNOTIC SEDATIVE AGENT; MEDETOMIDINE; NARCOTIC ANALGESIC AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DRUG COMBINATION; FEMALE; MALE; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL;

ACEPROMAZINE; ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; DOGS; DOPAMINE ANTAGONISTS; DRUG THERAPY, COMBINATION; FEMALE; HYPNOTICS AND SEDATIVES; MALE; MEDETOMIDINE; PREANESTHETIC MEDICATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 78650460867     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.237.12.1431     Document Type: Article

References (28)

1. Scheinin M, Schwinn DA. The locus coerulus. Site of hypnotic actions of alpha 2-adrenoceptor agonists? Anesthesiology 1992;76:873-875.
2. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
3. Murrell JC, Hellebrekers LJ. Medetomidine and dexmedetomidine, a review of cardiovascular effects and antinociceptive properties in the dog. Vet Anaesth Analg 2005;32:117-127.
4. Baldessarini RJ, Tarazi FI. Pharmacology of psychosis and mania. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill, 2006;461-500.
5. Hall LW, Clarke KW, Trim CM. Principles of sedation, analgesia and premedication. In: Hall LW, Clarke KW, Trim CM, eds. Veterinary anaesthesia. 10th ed. Edinburgh: WB Saunders Co, 2001;75-112.
6. Brodbelt DC, Young LE, Pfeiffer DU, et al. Update results from the Confidential Enquiry into Perioperative Small Animal Fatalities, in Proceedings. Spring Meet Assoc Vet Anaesth 2006;119-124.
7. Ossipov M, Harris S, Lloyd P, et al. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. Anesthesiology 1990;73:1227-1235.
8. American Society of Anesthesiologists. ASA physical status classification system. Available at: www.asahq.org/clinical/physicalstatus.html. Accessed Sep 11, 2007.
9. Young LE, Brearley JC, Richards DLS, et al. Medetomidine as a premedicant in dogs and its reversal by atipamezole. J Small Anim Pract 1990;31:554-559.
10. Kuusela E, Raekallio M, Anttila M, et al. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther 2000;23:15-20.
11. Kojima K, Nishimura R, Mutoh T, et al. Effects of medetomidine-midazolam, acepromazine-butorphanol, and midazolam-butorphanol on induction dose of thiopental and propofol and on cardiopulmonary changes in dogs. Am J Vet Res 2002;63:1671-1679.
12. Hall LW, Lagerweij E, Nolan AM, et al. Effect of medetomidine on the pharmacokinetics of propofol in dogs. Am J Vet Res 1994;55:116-120.
13. Vainio O. Propofol infusion anaesthesia in dogs premedicated with medetomidine. J Vet Anaesth 1991;18:35-37.
14. Murison PJ. Effect of propofol at two injection rates or thiopentone on post-intubation apnoea in the dog. J Small Anim Pract 2001;42:71-74.
15. Hammond RA, England GCW. The effect of medetomidine premedication upon propofol induction and infusion anaesthesia in the dog. J Vet Anaesth 1994;21:24-28.
16. Kuusela E, Raekallio M, Väisänen M, et al. Comparison of medetomidine and dexmedetomidine as premedicants in dogs undergoing propofol-isoflurane anesthesia. Am J Vet Res 2001;62:1073-1080.
17. Geel JK. The effect of premedication on the induction dose of propofol in dogs and cats. J S Afr Vet Assoc 1991;62:118-123.
18. Morgan DW, Legge K. Clinical evaluation of propofol as an intravenous anaesthetic agents in dogs and cats. Vet Rec 1989;124:31-33.
19. Robinson KJ, Jones RS, Cripps PJ. Effects of medetomidine and buprenorphine administered for sedation in dogs. J Small Anim Pract 2001;42:444-447.
20. Slingsby LS, Taylor PM, Waterman-Pearson AE. Effects of two doses of buprenorphine four or six hours apart on nociceptive thresholds, pain and sedation in dog after castration. Vet Rec 2006;159:705-711.
21. Brodbelt DC, Taylor PM, Stanway GW. A comparison of preoperative morphine and buprenorphine for post operative analgesia for arthrotomy in dogs. J Vet Pharmacol Ther 1997;20:284-289.
22. Wouters PF, Ven de Velde MA, Marcus MAE, et al. Hemodynamic changes during induction of anesthesia with eltanolone and propofol in dogs. Anesth Analg 1995;81:125-131.
23. Merin RG, Bernard J-M, Doursout M-F, et al. Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog. Anesthesiology 1991;74:568-574.
24. Bostrom I, Nyman G, Kampa N, et al. Effects of acepromazine on renal function in anesthetized dogs. Am J Vet Res 2003;64:590-598.
25. Stepien RL, Bonagura JD, Bednarski RM, et al. Cardiorespiratory effects of acepromazine maleate and buprenorphine hydrochloride in clinically normal dogs. Am J Vet Res 1995;56:78-84.
26. Pypendop BH, Verstegen JP. Haemodynamic effects of medetomidine in the dog, a dose titration study. Vet Surg 1998;27:612-622.
27. Valverde A, Cantwell S, Hernandez J, et al. Effects of acepromazine on the incidence of vomiting associated with opioid administration in dogs. Vet Anaesth Analg 2004;31:40-45.
28. Diehl KH, Hull R, Morton D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 2001;21:15-23.